FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine
The FDA issued an EUA for the Janssen COVID-19 Vaccine, allowing the vaccine to be distributed in the U.S for use in individuals 18 years of age and older.
The FDA issued an EUA for the Janssen COVID-19 Vaccine, allowing the vaccine to be distributed in the U.S for use in individuals 18 years of age and older.
Two studies presented at ASCO23 demonstrate the critical importance of access to comprehensive genomic profiling in patients with NSCLC and mCRC (Abstracts 3602 and 6506).
Afami-cel treatment resulted in durable responses in heavily pre-treated patients with HLA-A*02 and MAGE-A4-expressing synovial sarcoma. This study shows that T-cell receptor therapy can be…
Nature Reviews Drug Discovery – Discover the worldโs best science and medicine | Nature.com
Nature Reviews Genetics – This Review surveys the known mechanisms of communication between RBPs and their effectors and their roles in reducing the complexity of…
Review Article from The New England Journal of Medicine โ Key Issues as Wearable Digital Health Technologies Enter Clinical Care
Review Article from The New England Journal of Medicine โ Key Issues as Wearable Digital Health Technologies Enter Clinical Care
Development of medicines in rare oncologic patient populations are growing, but well-powered randomized controlled trials are typically extremely challenging or unethical to conduct in such…
Novel tissue-agnostic therapeutics targeting driver mutations in tumor cells have been recently approved by FDA, driven by basket trials that have demonstrated their efficacy and…
VivekSubbiah & colleagues delve into the @ASCO #TAPURStudy, shedding light on the importance of targeting ALL #BRAFAlterations, beyond V600E. (Re)-search continues, urging us to push…